The trifunctional antibody catumaxomab amplifies and shapes tumor-specific immunity when applied to gastric cancer patients in the adjuvant setting-Reference-Cited by-同舟云学术

The trifunctional antibody catumaxomab amplifies and shapes tumor-specific immunity when applied to gastric cancer patients in the adjuvant setting

Published:2013-12-01 Issue:12 Volume:9 Page:2533-2542
ISSN:2164-5515
Container-title:Human vaccines & immunotherapeutics
language:en
Short-container-title:vaccines

Author:

Atanackovic Djordje,Reinhard Henrike,Meyer Sabrina,Spöck Stefanie,Grob Tobias,Luetkens Tim,Yousef Sara,Cao Yanran,Hildebrandt York,Templin Julia,Bartels Katrin,Lajmi Nesrine,Stoiber Heribert,Kröger Nicolaus,Atz Judith,Seimetz Diane,Izbicki Jakob R,Bokemeyer Carsten

Publisher

Informa UK Limited

Subject

Pharmacology,Immunology,Immunology and Allergy

Link

http://www.tandfonline.com/doi/pdf/10.4161/hv.26065

Reference50 articles.

1. Epidemiology of gastric cancer;Crew;World J Gastroenterol,2006

2. Postoperative outcome and sites of recurrence in patients following curative resection of gastric cancer;Maehara;Br J Surg,2000

3. Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer;Cunningham;N Engl J Med,2006

4. Risk factors which predict pattern of recurrence after curative surgery for patients with advanced gastric cancer;Moriguchi;Surg Oncol,1992

5. Prospective study of peritoneal recurrence after curative surgery for gastric cancer;Roviello;Br J Surg,2003

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CD4 T-Cell Subsets and the Pathophysiology of Inflammatory Bowel Disease;International Journal of Molecular Sciences;2023-01-31

2. The Pathogenicity and Synergistic Action of Th1 and Th17 Cells in Inflammatory Bowel Diseases;Inflammatory Bowel Diseases;2022-09-27

3. Peritoneal carcinomatosis with intraperitoneal immunotherapy: current treatment options and perspectives;Expert Review of Gastroenterology & Hepatology;2022-09-02

4. T Cell Bispecific Antibodies: An Antibody-Based Delivery System for Inducing Antitumor Immunity;Pharmaceuticals;2021-11-17

5. Immune cell engagers in solid tumors: promises and challenges of the next generation immunotherapy;ESMO Open;2021-02